What You Need to Know From Inovio Pharmaceuticals' Q3 Update
Inovio Pharmaceuticals (NASDAQ: INO) continues to take investors on a roller coaster ride. The biotech stock was up close to 25% by late May, only to give up all of those gains and then some. A dilutive stock offering in July zapped all the momentum that Inovio had. The stock is now down nearly 30% year to date.
The company announced its third-quarter performance after the market closed on Wednesday. Was there anything in the update to give investors more confidence?
Image source: Getty Images.
Source: Fool.com